Primary information |
---|
sequence ID | Seq_1090 |
Peptide sequence | DAHKSEVAHRFKD |
CancerPDF_ID | CancerPDF_ID8607, CancerPDF_ID10184, CancerPDF_ID11342, |
PMID | 23667664,21805675,26992070 |
Protein Name | Serum albumin,Serum albumin precursor,Serum albumin |
UniprotKB Entry Name | ALBU_HUMAN,ALBU_HUMAN,ALBU_HUMAN |
Fluid | Serum,Urine,Serum |
M/Z | 1538.76,1539.7496,1538.759 |
Charge | 1,NA,NA |
Mass (in Da) | 1540.68,NA,1539.769016 |
fdr | NA,NA,NA |
Profiling Technique | MALDI-TOF,MALDI-TOF,LC-MS |
Peptide Identification technique | FT-ICR MS/MS + nano-HPLC,MALDI-TOF-MS,LC-MS/MS |
Quantification Technique | NA,NA,NA |
Labelled/Label Free | Label Free,Label Free,Label Free |
FDR | NA,1,FDR 1 % |
CancerPDF_ID | CancerPDF_ID8607, CancerPDF_ID10184, CancerPDF_ID11342, |
p-Value | NA,NA,NA |
Software | MASCOT,NA,SEQUEST and Maxquant |
Length | 13,13,13 |
Cancer Type | "Breast cancer, Lung cancer, Rectal cancer",Muscle-invasive bladder cancer,Melanoma |
Database | NA,SwissProt Database,SwissProt Database |
Modification | NA,NA,NA |
Number of Patients | "Breast Cancer =84, lung cancer= 70, Rectal cancer = 30patients; 500 healthy",751 bladder cancer and 127 control,8 cancer samples and 4 healthy samples |
Regulation | NA,Differentially expressed between cancer vs normal samples,"Present in 8 cancer samples out of 8 cancer samples. ,Present in 4 healthy samples out of 4 healthy samples." |
Validation | NA,Mann-Whitney tests and areas under receiver-operator characteristic,na |
Sensitivity | NA,NA,NA |
Specificity | NA,NA,NA |
Accuracy | NA,NA,NA |
Peptide Atlas | PeptideAtlas |
IEDB | 436751
|